Pancreatic ductal adenocarcinoma: metastatic disease
- PMID: 28623515
- DOI: 10.1007/s12094-017-1690-6
Pancreatic ductal adenocarcinoma: metastatic disease
Abstract
The treatment of choice of metastatic PADC is systemic chemotherapy. In the last decade, there have been significant advances in this area. New combination poli-chemotherapy schemes have shown a significant increase in overall survival and progression-free survival without impairing quality of life. In addition, the value of second-line chemotherapy treatment has consolidated and a new concept called "therapeutic sequencing" has also emerged. The aim of this article is to review the different therapeutic options in metastatic PDAC based on patient's characteristics.
Keywords: Management; Metastatic; Pancreatic ductal adenocarcinoma; Re-evaluation; Treatment sequencing.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical